Episode
What is driving the comeback story in biopharma?
- Podcast
- UBS Global Research Pod Hub
- Published
- Feb 13, 2026
- Duration seconds
- 911
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/ubs-global-research-pod-hub-6511142/episodes/what-is-driving-the-comeback-story-in-biopharma/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/ubs-global-research-pod-hub-6511142/what-is-driving-the-comeback-story-in-biopharma.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
With drug pricing cuts easing, investor interest is returning, driven by fresh innovation, active M&A, and rotation into a long undervalued sector. Dimiter Tassev, UBS Healthcare Advisory Sales Specialist, speaks with Michael Yee, Global Head of Biotechnology Research at UBS investment Bank, about the outlook for US biopharma. *(This information is subject to a disclaimer at the end of this podcast. Please ensure that you listen to the disclaimer and go to www.ubs.com for further information about UBS).